This inventor holds 44 USPTO granted patents and 2 published patent applications, plus 9 CIPO patents, primarily in Sweetening Technologies. Top assignees: General Foods Limited, Kraft General Foods, Inc.. Active years: 1984-1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hopewell Junction, NY (US) (1984 - 1985)
- Port Chester, NY (US) (1985 - 1987)
- Nanuet, NY (US) (1985 - 1991)
Company Filing History:
Years Active: 1984-1991
Areas of Expertise:
Title: Paul R. Zanno: Innovator in Sweetness Inhibition
Introduction: Paul R. Zanno is a distinguished inventor based in Nanuet, NY, known for his significant contributions to the field of pharmaceutical preparations. With an impressive portfolio of 44 patents, Zanno has dedicated his career to advancing innovations that enhance product formulations, particularly in the realm of sweetness inhibition.
Latest Patents: Among his latest patents, Zanno has developed a compelling solution for sweetness inhibition in pharmaceutical products. One of his recent inventions is a sweetness inhibitor for pharmaceutical preparations, which describes a process and product that incorporates an effective sweetness-inhibiting amount of specific compounds. These compounds include alkali metal heptyl sulfonate, alkaline earth metal heptyl sulfonate, alkali metal octyl sulfonate, and alkaline earth metal octyl sulfonate. This innovative approach provides a means to add a sweetener to an ingestible composition while effectively mitigating unwanted sweetness, thereby improving user experience in pharmaceutical applications.
Career Highlights: Throughout his career, Paul R. Zanno has been associated with notable companies such as General Foods Limited and Kraft General Foods, Inc. His work in these organizations allowed him to harness his skills and develop inventions that have had a lasting impact on food and pharmaceutical industries.
Collaborations: Zanno has collaborated with esteemed colleagues, including Ronald E. Barnett and Glenn M. Roy. Their collective efforts have contributed to the development of groundbreaking products and processes, reaffirming Zanno's status as a leading innovator in his field.
Conclusion: Paul R. Zanno's contributions to sweetness inhibition and pharmaceutical preparations illustrate the importance of innovation in enhancing product formulations. His extensive patent portfolio and collaborations highlight a commitment to advancing technology that benefits both the industry and consumers. As he continues to develop new solutions, Zanno remains a vital figure in the realm of inventions that address complex challenges in pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile